Your browser doesn't support javascript.
loading
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Johnson, Matthew G; Puenpatom, Amy; Moncada, Pablo Andrés; Burgess, Lesley; Duke, Elizabeth R; Ohmagari, Norio; Wolf, Timo; Bassetti, Matteo; Bhagani, Sanjay; Ghosn, Jade; Zhang, Ying; Wan, Hong; Williams-Diaz, Angela; Brown, Michelle L; Paschke, Amanda; De Anda, Carisa.
  • Johnson MG; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Puenpatom A; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Moncada PA; Fundacion Valle del Lili, Cali, Colombia (P.A.M.).
  • Burgess L; TREAD Research, Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and Stellenbosch University, Parow, South Africa (L.B.).
  • Duke ER; Fred Hutchinson Cancer Research Center, Seattle, Washington (E.R.D.).
  • Ohmagari N; National Center for Global Health and Medicine, Tokyo, Japan (N.O.).
  • Wolf T; Universitätsklinikum Frankfurt, Frankfurt am Main, Germany (T.W.).
  • Bassetti M; IRCCS Ospedale Policlinico San Martino, and Department of Health Sciences, University of Genoa, Genova, Italy (M.B.).
  • Bhagani S; Royal Free London NHS Foundation Trust, London, United Kingdom (S.B.).
  • Ghosn J; AP-HP. Nord, Hôpital Bichat - Claude Bernard, and Université Paris Cité, INSERM UMR 1137 IAME, Paris, France (J.G.).
  • Zhang Y; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Wan H; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Williams-Diaz A; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Brown ML; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • Paschke A; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
  • De Anda C; Merck & Co., Inc., Rahway, New Jersey (M.G.J., A.P., Y.Z., H.W., A.W., M.L.B., A.P., C.D.).
Ann Intern Med ; 175(8): 1126-1134, 2022 08.
Article en En | MEDLINE | ID: mdl-35667065
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article